Trial intelligence / Profile preview

Olanzapine Monotherapy for Bipolar I Depression

NCT01303601Phase 4Completed

Sponsor
China Medical University
Start
Jan 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of olanzapine in bipolar I disorder, sponsored by China Medical University. Started Jan 2009; status: completed.

02

Drugs

olanzapine
03

Conditions

bipolar I disorder

Beyond the preview

Go deeper on NCT01303601.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01303601.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call